ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
-28.56%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
AUM
$185M
AUM Growth
+$185M
Cap. Flow
-$2.11M
Cap. Flow %
-1.14%
Top 10 Hldgs %
89.7%
Holding
21
New
Increased
Reduced
2
Closed

Top Buys

No buys this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$61.6M 33.24%
6,068,125
GLUE icon
2
Monte Rosa Therapeutics
GLUE
$296M
$20.6M 11.14%
1,472,331
SNDX icon
3
Syndax Pharmaceuticals
SNDX
$1.41B
$17.8M 9.61%
1,025,000
HRMY icon
4
Harmony Biosciences
HRMY
$2.12B
$16.7M 9%
342,815
-12,600
-4% -$613K
NUVB icon
5
Nuvation Bio
NUVB
$1.02B
$13.4M 7.21%
2,541,009
ACRS icon
6
Aclaris Therapeutics
ACRS
$209M
$10.9M 5.9%
634,455
ELEV
7
DELISTED
Elevation Oncology
ELEV
$7.14M 3.86%
2,834,910
TRML icon
8
Tourmaline Bio
TRML
$601M
$6.72M 3.63%
682,923
VRNA
9
Verona Pharma
VRNA
$9.16B
$6.65M 3.59%
1,332,485
PSTX
10
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$4.67M 2.52%
1,043,267
SYRE icon
11
Spyre Therapeutics
SYRE
$996M
$3.89M 2.1%
1,691,151
BMEA icon
12
Biomea Fusion
BMEA
$116M
$3.56M 1.92%
798,757
OKUR
13
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$2.61M 1.41%
886,075
SPRB
14
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$2.42M 1.31%
1,205,511
MRKR icon
15
Marker Therapeutics
MRKR
$12M
$1.38M 0.75%
3,142,857
VIRX
16
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.37M 0.74%
288,571
TECX
17
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$1.33M 0.72%
1,009,779
BCEL
18
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$1.23M 0.66%
387,653
ZSAN
19
DELISTED
Zosano Pharma Corporation
ZSAN
$612K 0.33%
2,718,226
OBSV
20
DELISTED
ObsEva SA Ordinary Shares
OBSV
$596K 0.32%
394,838
-991,500
-72% -$1.5M
NBRV
21
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$80K 0.04%
191,028